BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11197728)

  • 1. BEHAB/brevican: an extracellular matrix component associated with invasive glioma.
    Gary SC; Hockfield S
    Clin Neurosurg; 2000; 47():72-82. PubMed ID: 11197728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas.
    Viapiano MS; Bi WL; Piepmeier J; Hockfield S; Matthews RT
    Cancer Res; 2005 Aug; 65(15):6726-33. PubMed ID: 16061654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain enriched hyaluronan binding (BEHAB)/brevican increases aggressiveness of CNS-1 gliomas in Lewis rats.
    Nutt CL; Zerillo CA; Kelly GM; Hockfield S
    Cancer Res; 2001 Oct; 61(19):7056-9. PubMed ID: 11585735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracranial injury acutely induces the expression of the secreted isoform of the CNS-specific hyaluronan-binding protein BEHAB/brevican.
    Jaworski DM; Kelly GM; Hockfield S
    Exp Neurol; 1999 Jun; 157(2):327-37. PubMed ID: 10364444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BEHAB (brain enriched hyaluronan binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines.
    Jaworski DM; Kelly GM; Piepmeier JM; Hockfield S
    Cancer Res; 1996 May; 56(10):2293-8. PubMed ID: 8625302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial tumor invasion: a role for the upregulation and cleavage of BEHAB/brevican.
    Nutt CL; Matthews RT; Hockfield S
    Neuroscientist; 2001 Apr; 7(2):113-22. PubMed ID: 11496922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BEHAB/brevican: a brain-specific lectican implicated in gliomas and glial cell motility.
    Gary SC; Kelly GM; Hockfield S
    Curr Opin Neurobiol; 1998 Oct; 8(5):576-81. PubMed ID: 9811619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion.
    Viapiano MS; Hockfield S; Matthews RT
    J Neurooncol; 2008 Jul; 88(3):261-72. PubMed ID: 18398576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a cleaved brain-specific extracellular matrix protein mediates glioma cell invasion In vivo.
    Zhang H; Kelly G; Zerillo C; Jaworski DM; Hockfield S
    J Neurosci; 1998 Apr; 18(7):2370-6. PubMed ID: 9502798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel membrane-associated glycovariant of BEHAB/brevican is up-regulated during rat brain development and in a rat model of invasive glioma.
    Viapiano MS; Matthews RT; Hockfield S
    J Biol Chem; 2003 Aug; 278(35):33239-47. PubMed ID: 12799382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ECM-mediated glioma cell invasion.
    Goldbrunner RH; Bernstein JJ; Tonn JC
    Microsc Res Tech; 1998 Nov; 43(3):250-7. PubMed ID: 9840803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular matrix alterations in brains lacking four of its components.
    Rauch U; Zhou XH; Roos G
    Biochem Biophys Res Commun; 2005 Mar; 328(2):608-17. PubMed ID: 15694392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brevican: a major proteoglycan in adult brain.
    Yamaguchi Y
    Perspect Dev Neurobiol; 1996; 3(4):307-17. PubMed ID: 9117262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-enriched hyaluronan binding (BEHAB)/brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member.
    Matthews RT; Gary SC; Zerillo C; Pratta M; Solomon K; Arner EC; Hockfield S
    J Biol Chem; 2000 Jul; 275(30):22695-703. PubMed ID: 10801887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invadopodia: at the cutting edge of tumour invasion.
    Stylli SS; Kaye AH; Lock P
    J Clin Neurosci; 2008 Jul; 15(7):725-37. PubMed ID: 18468901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of extracellular matrix components in a highly infiltrative in vivo glioma model.
    Mahesparan R; Read TA; Lund-Johansen M; Skaftnesmo KO; Bjerkvig R; Engebraaten O
    Acta Neuropathol; 2003 Jan; 105(1):49-57. PubMed ID: 12471461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cDNA cloning, chromosomal localization, and expression analysis of human BEHAB/brevican, a brain specific proteoglycan regulated during cortical development and in glioma.
    Gary SC; Zerillo CA; Chiang VL; Gaw JU; Gray G; Hockfield S
    Gene; 2000 Oct; 256(1-2):139-47. PubMed ID: 11054543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase-19 is highly expressed in astroglial tumors and promotes invasion of glioma cells.
    Lettau I; Hattermann K; Held-Feindt J; Brauer R; Sedlacek R; Mentlein R
    J Neuropathol Exp Neurol; 2010 Mar; 69(3):215-23. PubMed ID: 20142769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular matrix components associated with remodeling processes in brain.
    Rauch U
    Cell Mol Life Sci; 2004 Aug; 61(16):2031-45. PubMed ID: 15316653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of BEHAB/Brevican in the Tumor Microenvironment: Mediating Glioma Cell Invasion and Motility.
    Giamanco KA; Matthews RT
    Adv Exp Med Biol; 2020; 1272():117-132. PubMed ID: 32845505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.